The development of a corporate strategy is the key driver for the eventual success of any pharmaceutical company. The development of a strategy unique to the company’s expertise and capabilities is critical to success. The end-goal of the corporate strategy is often to complete a merger as growing organically is not a viable option. Plexsus can help with all types of merger and acquisition transactions and has in its network a team with first-hand experience.
The team have advised on complex and challenging M&A transactions in Australasia, North America, and Europe. This experience includes public and private companies involved in a broad range of transactions:
Mergers
|
Acquisitions
|